Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

The effects of reimbursement mechanisms on medical technology diffusion in the hospital sector in the Italian NHS.

Finocchiaro Castro M, Guccio C, Pignataro G, Rizzo I.

Health Policy. 2014 Apr;115(2-3):215-29. doi: 10.1016/j.healthpol.2013.12.004. Epub 2013 Dec 16.

PMID:
24393709
2.

DRG-based hospital payment systems and technological innovation in 12 European countries.

Scheller-Kreinsen D, Quentin W, Busse R.

Value Health. 2011 Dec;14(8):1166-72. doi: 10.1016/j.jval.2011.07.001. Epub 2011 Sep 9.

3.

Diffusion of medical technology: the role of financing.

Cappellaro G, Ghislandi S, Anessi-Pessina E.

Health Policy. 2011 Apr;100(1):51-9. doi: 10.1016/j.healthpol.2010.10.004. Epub 2010 Nov 4.

PMID:
21055840
4.

Coronary stents and the uptake of new medical devices in the German system of inpatient reimbursement.

Henschke C, Baeumler M, Gaskins M, Busse R.

J Interv Cardiol. 2010 Dec;23(6):546-53. doi: 10.1111/j.1540-8183.2010.00592.x. Epub 2010 Aug 23.

PMID:
20735711
5.

Reimbursement systems and quality of hospital care: an empirical analysis for Italy.

Cavalieri M, Gitto L, Guccio C.

Health Policy. 2013 Aug;111(3):273-89. doi: 10.1016/j.healthpol.2013.05.014. Epub 2013 Jul 2.

PMID:
23830561
6.

Diagnosis related group prospective payment: implications for health care and medical technology.

Davis K, Anderson G, Steinberg E.

Health Policy. 1984;4(2):139-47.

PMID:
10310958
7.

Do diagnosis-related group-based payments incentivise hospitals to adjust output mix?

Liang LL.

Health Econ. 2015 Apr;24(4):454-69. doi: 10.1002/hec.3033. Epub 2014 Feb 12.

PMID:
24519749
8.

Access to innovation: is there a difference in the use of expensive anticancer drugs between French hospitals?

Bonastre J, Chevalier J, Van der Laan C, Delibes M, De Pouvourville G.

Health Policy. 2014 Jun;116(2-3):162-9. doi: 10.1016/j.healthpol.2013.11.006. Epub 2013 Nov 20.

PMID:
24314625
9.

Prospective reimbursement and the diffusion of new technologies in hospitals.

Romeo AA, Wagner JL, Lee RH.

J Health Econ. 1984 Apr;3(1):1-24.

PMID:
10273511
10.

Using Australian DRGs in Germany: a commentary.

Hindle D, Lenz MJ.

Aust Health Rev. 2001;24(1):136-47.

PMID:
11357728
11.

[Procedure of implementation of new methods of examination and treatment in the G-DRG system (NUB procedure)].

Brechmann T, Schmiegel W.

Med Klin (Munich). 2007 Aug 15;102(8):683-4. German. No abstract available.

PMID:
17694288
12.

[Comparison of hand surgery in the German and Italian DRG systems].

Lotter O, Dolderer J, Stahl S, Atzei A, Haerle M, Schaller HE.

Gesundheitswesen. 2011 Dec;73(12):843-8. doi: 10.1055/s-0030-1265194. Epub 2010 Sep 30. German.

PMID:
20886418
13.

The diffusion of innovations in hospitals. Some econometric considerations.

Lee RH, Waldman DM.

J Health Econ. 1985 Dec;4(4):373-80.

PMID:
10276360
14.

How innovative are pharmaceutical innovations?: the case of medicines financed through add-on payments outside of the French DRG-based hospital payment system.

Gridchyna I, Aulois-Griot M, Maurain C, Bégaud B.

Health Policy. 2012 Jan;104(1):69-75. doi: 10.1016/j.healthpol.2011.11.007. Epub 2011 Dec 1.

PMID:
22136813
15.

Technology diffusion and substitution of medical innovations.

Serra-Sastre V, McGuire A.

Adv Health Econ Health Serv Res. 2012;23:149-75.

PMID:
23156664
16.

Interhospital differences in severity of illness. Problems for prospective payment based on diagnosis-related groups (DRGs).

Horn SD, Bulkley G, Sharkey PD, Chambers AF, Horn RA, Schramm CJ.

N Engl J Med. 1985 Jul 4;313(1):20-4.

PMID:
3923354
17.

Childbirth and Diagnosis Related Groups (DRGs): patient classification and hospital reimbursement in 11 European countries.

Bellanger MM, Quentin W, Tan SS.

Eur J Obstet Gynecol Reprod Biol. 2013 May;168(1):12-9. doi: 10.1016/j.ejogrb.2012.12.027. Epub 2013 Jan 30. Review.

PMID:
23375210
18.

[DRGs as future reimbursement system for hospital services exemplified by multiple sclerosis].

Petereit HF, Ruffing G, Weilbach FX, Zessack N, Zettl UK.

Nervenarzt. 2002 Aug;73(8):785-91. German.

PMID:
12242969
19.

[Risks for patient safety in the DRG era].

Maio G.

Z Evid Fortbild Qual Gesundhwes. 2014;108(1):32-4. doi: 10.1016/j.zefq.2014.01.025. Epub 2014 Feb 18. German. No abstract available.

PMID:
24602525
20.

Cost accounting and public reimbursement schemes in Spanish hospitals.

Sánchez-Martínez F, Abellán-Perpiñán JM, Martínez-Pérez JE, Puig-Junoy J.

Health Care Manag Sci. 2006 Aug;9(3):225-32.

PMID:
17016928

Supplemental Content

Support Center